​

Solventum (SOLV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SOLV Stock Forecast

Solventum (SOLV) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $84.89, with a high of $113.00 and a low of $35.00. This represents a -6.07% decline from the last price of $90.38.

$35 $51 $67 $83 $99 $115 High: $113 Avg: $84.89 Low: $35 Last Closed Price: $90.38

SOLV Stock Rating

Solventum stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (75.00%), 2 Hold (16.67%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 2 9 Strong Sell Sell Hold Buy Strong Buy

SOLV Price Target Upside V Benchmarks

TypeNameUpside
StockSolventum-6.07%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks5.78%

Price Target Trends

1M3M12M
# Anlaysts1120
Avg Price Target$35.00$35.00$89.85
Last Closing Price$90.38$90.38$90.38
Upside/Downside-61.27%-61.27%-0.59%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 261751115
Oct, 261751115
Sep, 261751115
Aug, 261751115
Jul, 261652115
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 28, 2026CIBC$35.00$82.00-57.32%-61.27%
Aug 06, 2026Stifel Nicolaus$100.00$84.8217.90%10.64%
Aug 06, 2026Patrick WoodUBS$101.00$87.4715.47%11.75%
Aug 06, 2026Mizuho Securities$113.00$87.4729.19%25.03%
Aug 06, 2026KeyBanc$102.00$87.4716.61%12.86%
Aug 06, 2026Ryan ZimmermanBTIG$95.00$87.478.61%5.11%
Jul 28, 2026UBS$95.00$80.4718.06%5.11%
Jul 13, 2026BTIG$91.00$76.7018.64%0.69%
Jul 08, 2026BMO Capital$81.00$75.187.74%-10.38%
Jun 01, 2026Jefferies$43.00$74.95-42.63%-52.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2026BTIGBuyBuyhold
Oct 08, 2026BenchmarkBuyBuyhold
Aug 25, 2026Cowen & Co.HoldHoldhold
Aug 06, 2026UBSBuyBuyhold
Aug 06, 2026KeyBancOverweightOverweighthold
Aug 06, 2026BTIGBuyBuyhold
Jul 28, 2026UBSNeutralBuyupgrade
Jul 13, 2026BTIGBuyBuyhold
Jul 08, 2026BMO CapitalMarket Performinitialise
May 15, 2026WedbushOutperforminitialise

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 $9 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.79$2.77$8.94---
Avg Forecast-$6.59$5.50$5.87$6.19$6.30
High Forecast-$6.62$5.76$6.35$6.26$6.37
Low Forecast-$6.57$5.23$5.29$6.13$6.23
Surprise %--57.97%62.55%---

Revenue Forecast

$8B $8B $8B $8B $9B $9B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.20B$8.25B$8.32B---
Avg Forecast$8.20B$8.23B$8.26B$8.41B$8.48B$8.57B
High Forecast$8.27B$8.31B$8.33B$8.41B$8.48B$8.65B
Low Forecast$8.13B$8.22B$8.22B$8.40B$8.48B$8.50B
Surprise %-0.27%0.76%---

Net Income Forecast

$0 $400M $800M $1B $2B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$479.00M$1.56B---
Avg Forecast-$1.14B$947.53M$1.00B$1.07B$1.09B
High Forecast-$1.14B$993.31M$1.09B$1.08B$1.10B
Low Forecast-$1.13B$901.75M$911.80M$1.06B$1.08B
Surprise %--57.89%64.22%---

SOLV Forecast FAQ

Is Solventum stock a buy?

Solventum stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Solventum is a favorable investment for most analysts.

What is Solventum's price target?

Solventum's price target, set by 12 Wall Street analysts, averages $84.89 over the next 12 months. The price target range spans from $35 at the low end to $113 at the high end, suggesting a potential -6.07% change from the previous closing price of $90.38.

How does Solventum stock forecast compare to its benchmarks?

Solventum's stock forecast shows a -6.07% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (5.78%).

What is the breakdown of analyst ratings for Solventum over the past three months?

  • November 2026: 6.67% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 6.67% Strong Sell.
  • October 2026: 6.67% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 6.67% Strong Sell.
  • September 2026: 6.67% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 6.67% Strong Sell.

What is Solventum’s EPS forecast?

Solventum's average annual EPS forecast for its fiscal year ending in December 2026 is $5.87, marking a -34.34% decrease from the reported $8.94 in 2025. Estimates for the following years are $6.19 in 2027, and $6.3 in 2028.

What is Solventum’s revenue forecast?

Solventum's average annual revenue forecast for its fiscal year ending in December 2026 is $8.41B, reflecting a 1.00% increase from the reported $8.32B in 2025. The forecast for 2027 is $8.48B, and $8.57B for 2028.

What is Solventum’s net income forecast?

Solventum's net income forecast for the fiscal year ending in December 2026 stands at $1B, representing a -35.52% decrease from the reported $1.56B in 2025. Projections indicate $1.07B in 2027, and $1.09B in 2028.